Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas
Miguel Melo, Adriana Gaspar da Rocha, João Vinagre, et al.
The Journal of Clinical Endocrinology & Metabolism (2014) Vol. 99, Iss. 5, pp. E754-E765
Open Access | Times Cited: 510

Showing 26-50 of 510 citing articles:

Effects of CoexistentBRAFV600EandTERTPromoter Mutations on Poor Clinical Outcomes in Papillary Thyroid Cancer: A Meta-Analysis
Shinje Moon, Young Shin Song, Ye An Kim, et al.
Thyroid (2017) Vol. 27, Iss. 5, pp. 651-660
Closed Access | Times Cited: 140
Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene
Muhammad Khairul Ramlee, Jing Wang, Wei Hong Toh, et al.
Genes (2016) Vol. 7, Iss. 8, pp. 50-50
Open Access | Times Cited: 139
Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications
Tiantian Liu, Xiaotian Yuan, Dawei Xu
Genes (2016) Vol. 7, Iss. 7, pp. 38-38
Open Access | Times Cited: 137
Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance
Giorgia Acquaviva, Michela Visani, Andrea Repaci, et al.
Histopathology (2017) Vol. 72, Iss. 1, pp. 6-31
Open Access | Times Cited: 130
Distinct clinicopathological features of NAB2-STAT6 fusion gene variants in solitary fibrous tumor with emphasis on the acquisition of highly malignant potential
Keisuke Akaike, Aiko Kurisaki‐Arakawa, Kieko Hara, et al.
Human Pathology (2014) Vol. 46, Iss. 3, pp. 347-356
Open Access | Times Cited: 129
Tumor Genotype Determines Phenotype and Disease-related Outcomes in Thyroid Cancer
Linwah Yip, Marina N. Nikiforova, Jenny Yoo, et al.
Annals of Surgery (2015) Vol. 262, Iss. 3, pp. 519-525
Open Access | Times Cited: 127
TERT Promoter Mutations in Skin Cancer: The Effects of Sun Exposure and X-Irradiation
Helena Pópulo, Paula Boaventura, João Vinagre, et al.
Journal of Investigative Dermatology (2014) Vol. 134, Iss. 8, pp. 2251-2257
Open Access | Times Cited: 125
TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease
Miguel Melo, Adriana Gaspar da Rocha, Rui Batısta, et al.
The Journal of Clinical Endocrinology & Metabolism (2017) Vol. 102, Iss. 6, pp. 1898-1907
Open Access | Times Cited: 125
Low risk papillary thyroid cancer
Juan P. Brito, Ian D. Hay, John C. Morris
BMJ (2014) Vol. 348, Iss. jun16 9, pp. g3045-g3045
Closed Access | Times Cited: 122
TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma
Greta Gandolfi, Moira Ragazzi, Andrea Frasoldati, et al.
European Journal of Endocrinology (2015) Vol. 172, Iss. 4, pp. 403-413
Open Access | Times Cited: 120
Thyroid Cancer: Risk-Stratified Management and Individualized Therapy
Friedhelm Raue, Karin Frank‐Raue
Clinical Cancer Research (2016) Vol. 22, Iss. 20, pp. 5012-5021
Closed Access | Times Cited: 118
Genetic landscape of papillary thyroid carcinoma in the Chinese population
Jialong Liang, Wanshi Cai, Dongdong Feng, et al.
The Journal of Pathology (2017) Vol. 244, Iss. 2, pp. 215-226
Closed Access | Times Cited: 118
Molecular approaches to thyroid cancer diagnosis
Susan J. Hsiao, Yuri E. Nikiforov
Endocrine Related Cancer (2014)
Open Access | Times Cited: 117
Telomerase promoter mutations in cancer: an emerging molecular biomarker?
João Vinagre, Vasco Pinto, Ricardo Celestino, et al.
Virchows Archiv (2014) Vol. 465, Iss. 2, pp. 119-133
Open Access | Times Cited: 117
Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma-A meta-analysis
Huy Gia Vuong, Ahmed Altibi, Uyen Duong, et al.
Clinical Endocrinology (2017) Vol. 87, Iss. 5, pp. 411-417
Open Access | Times Cited: 116
Follicular cell-derived thyroid cancer
Henning Dralle, Andreas Machens, Johanna Basa, et al.
Nature Reviews Disease Primers (2015) Vol. 1, Iss. 1
Closed Access | Times Cited: 115
Clinical and Molecular Features of Hürthle Cell Carcinoma of the Thyroid
Ana-Maria Chindris, John D. Casler, Victor Bernet, et al.
The Journal of Clinical Endocrinology & Metabolism (2014) Vol. 100, Iss. 1, pp. 55-62
Open Access | Times Cited: 113
BRAFandTERTpromoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients
Langping Jin, Endong Chen, Siyang Dong, et al.
Oncotarget (2016) Vol. 7, Iss. 14, pp. 18346-18355
Open Access | Times Cited: 113
Telomere Maintenance Mechanisms in Cancer
Tiago Bordeira Gaspar, Ana Sá, José Manuel Lopes, et al.
Genes (2018) Vol. 9, Iss. 5, pp. 241-241
Open Access | Times Cited: 113
TERT Promoter Mutation Predicts Radioiodine-Refractory Character in Distant Metastatic Differentiated Thyroid Cancer
Xue Yang, Jiao Li, Xiaoyi Li, et al.
Journal of Nuclear Medicine (2016) Vol. 58, Iss. 2, pp. 258-265
Open Access | Times Cited: 108
TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA
Na Wang, Tiantian Liu, Anastasios Sofiadis, et al.
Cancer (2014) Vol. 120, Iss. 19, pp. 2965-2979
Open Access | Times Cited: 107
Telomerase in differentiated thyroid cancer: Promoter mutations, expression and localization
Marina Muzza, Carla Colombo, Stefania Rossi, et al.
Molecular and Cellular Endocrinology (2014) Vol. 399, pp. 288-295
Closed Access | Times Cited: 105
Molecular Alterations in Thyroid Carcinoma
Mohamed Rizwan Haroon Al Rasheed, Bin Xu
Surgical pathology clinics (2019) Vol. 12, Iss. 4, pp. 921-930
Open Access | Times Cited: 101
Telomeres and telomerase in oncogenesis (Review)
Tomasz Trybek, Artur Kowalik, Stanisław Góźdż, et al.
Oncology Letters (2020) Vol. 20, Iss. 2, pp. 1015-1027
Open Access | Times Cited: 95
TERT Promoter Mutations in Papillary Thyroid Microcarcinomas
Dario de Biase, Greta Gandolfi, Moira Ragazzi, et al.
Thyroid (2015) Vol. 25, Iss. 9, pp. 1013-1019
Closed Access | Times Cited: 93

Scroll to top